Novo Nordisk (NVO) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Novo Nordisk, as the data feed reports them.

Analysts' mean target, 12 analysts
$45.76
12.4% above the price

The 12 analysts reported by the data feed have a mean price target for Novo Nordisk of $45.76, 12.4% above the $40.70 price (range $39.45–$64.11). 1.21% of the float was sold short as of Oct 30, 2026. Institutions hold 10.1% of the shares and insiders 0.0%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$45.76+12.4% vs price
Analysts
12
Short interest
1.21%of float, Oct 30, 2026
Short ratio
3.41 days
Institutions
10.1%
Insiders
0.00%
Beta
0.37
Next earnings
Feb 3, 2027

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

12 analysts covering Novo Nordisk, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $40.70.

Analysts' price targets for Novo Nordisk
Mean price target$45.7612.4% above the price (+12.4%)
Median price target$43.547.0% above the price (+7.0%)
Highest target$64.1157.5% above the price (+57.5%)
Lowest target$39.453.1% below the price (−3.1%)
Analysts with a target12

Ratings this month · 14 analysts

Buy 3(21%)Hold 10(71%)Sell 1(7%)
Analysts' ratings of Novo Nordisk this month, by rating
RatingAnalystsShare
Strong buy00%
Buy321%
Hold1071%
Sell17%
Strong sell00%

The feed averages these to 2.71 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “hold”.

Who owns Novo Nordisk

Ownership of Novo Nordisk
Held by institutions10.1%1,512 institutions; percent of shares outstanding
Held by institutions, of the float10.1%
Held by insiders0.00%percent of shares outstanding
Shares outstanding3.33B
Float3.16Bshares available to trade
Insiders' net purchases, six months00 purchases (0 shares), 0 sales

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Novo Nordisk
Shares short38.29Mas of Oct 30, 2026
Percent of float1.21%shares short ÷ float
Percent of shares outstanding0.87%shares short ÷ shares outstanding
Short ratio (days to cover)3.41shares short ÷ average daily volume

Novo Nordisk short interest from FINRA, with its history

Trading figures

Trading figures for Novo Nordisk
Beta0.37movement against the market; 1 moves with it
52-week high$64.16
52-week low$35.12
Average volume, 3 months12.39Mshares a day
Average volume, 10 days14.01Mshares a day

Dates to know

Upcoming and recent dates for Novo Nordisk
Next earnings reportFeb 3, 2027
Ex-dividend dateAug 17, 2026as the feed lists it
Dividend payment dateAug 25, 2026

Questions and answers

What is the analysts' price target for Novo Nordisk (NVO)?

As reported by the data feed, the mean price target of the 12 analysts covering Novo Nordisk is $45.76, 12.4% above the latest price of $40.70. The highest target is $64.11 and the lowest $39.45. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Novo Nordisk stock?

Of the 14 ratings the data feed reports for the current month, 0 are strong buy, 3 buy, 10 hold, 1 sell and 0 strong sell.

How many Novo Nordisk shares are sold short?

As reported by the data feed, 38.29M shares were sold short, 1.21% of the float as of Oct 30, 2026. At the average daily volume that is 3.41 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Novo Nordisk stock?

As reported by the data feed, institutions hold 10.1% of the shares (1,512 institutions) and insiders 0.0%. There are 3.33B shares outstanding, of which 3.16B are in the float.

When is Novo Nordisk's next earnings report?

The data feed lists Feb 3, 2027. The latest ex-dividend date it lists is Aug 17, 2026.

How much does Novo Nordisk stock move with the market?

Its beta, as reported by the data feed, is 0.37: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $35.12 and $64.16.

Cite this page

Funkfolio, “Novo Nordisk (NVO) statistics: analyst targets and short interest”, data as of 17 November 2026. https://funkfolio.com/stock/NVO/statistics

Underlying data: Yahoo Finance.